Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AEterna Zentaris Inc (NASDAQ:AEZS)

2.73
Delayed Data
As of 12:07pm ET
 +0.025 / +0.93%
Today’s Change
2.35
Today|||52-Week Range
5.59
-24.31%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close2.70
Today’s open2.70
Day’s range2.70 - 2.80
Volume112,351
Average volume (3 months)381,066
Market cap$31.5M
Dividend yield--
Data as of 12:07pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+35.21%
Earnings growth (this year)+86.88%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+4,854.55%
P/E ratio--
Price/Sales28.00
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
PRTOProteon Therapeutics...+0.10+5.26%
ABACAoxin Tianli Group I...-0.04-1.10%
OPGNOpGen Inc-0.05-4.10%
RKDAArcadia Biosciences ...+0.02+1.90%
Data as of 12:20pm ET, 01/19/2017

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$545.0K
Annual profit (last year)-$50.1M
Net profit margin-9,216.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David A. Dodd
Chief Accounting Officer &
Vice President-Finance
Geneviève Lemaire
Corporate headquarters
Montréal, Qubec

Forecasts


Search for Jobs